FDA approves first mRNA flu vaccine. Here’s what it could mean for future medicines
Although there are many possibilities for what researchers can use mRNA to treat, some important limitations remain
Search fresh public links, source activity, and ready-to-use post angles for Mrna Vaccines.
Fresh curated links around mRNA vaccines are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Although there are many possibilities for what researchers can use mRNA to treat, some important limitations remain
FRIDAY, Aug. 7, 2026 — The U.S. Food and Drug Administration (FDA) has approved the first flu vaccine built on messenger RNA (mRNA) technology, months after the agency refused to e...
A new mRNA vaccine strategy designed to activate antitumor immunity without undermining the production of vaccine antigens has shown promising results in mouse models, according to...
Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine … Source
A personalised mRNA cancer vaccine has produced positive results in a final-stage trial involving skin cancer, raising hopes that this approach could work against many cancers
This flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a standard flu jab
Messenger RNA transformed vaccine science during the COVID-19 pandemic, but its success depended on a delivery system capable of protecting a fragile genetic molecule and transport...
The FDA will soon decide whether to approve the first flu vaccine that uses the same mRNA technology as COVID-19 shots. Health Secretary Robert F. Kennedy Jr. has long questioned m...
The clearance paves the way for the first preventive flu shot based on mRNA technology and completes a dramatic regulatory turnaround.
In a somewhat surprise announcement, the Food and Drug Administration (FDA) has approved the first US influenza vaccine built on Moderna's mRNA technology that gave us one of...
The FDA approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The Food and Drug Administration is expected to decide whether to approve the first mRNA flu vaccine.
Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) vừa phê duyệt vaccine phòng cúm mùa đầu tiên sỠdụng công nghệ mRNA tại Mỹ.
The Food and Drug Administration on Wednesday approved the first mRNA flu vaccine, enabling use of a technology that will make it easier to rapidly target a widely prevalent or par...
The Food and Drug Administration (FDA) late Wednesday approved the nation's first mRNA flu vaccine, manufactured by drugmaker Moderna.
Here are seven mRNA biotechs that have raised funds in recent years to push their candidates ahead through preclinical and clinical trials. The post Seven companies leading the mRN...
The FDA approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
The Food and Drug Administration on Wednesday approved the U.S.’s first flu shot that uses mRNA technology: mFlusiva, from drugmaker Moderna. The FDA granted approval for two ag...
These new trials have shown great results. Gizmodo: On Wednesday, the companies disclosed the primary findings of a Phase 3 trial that tested their mRNA-based vaccine, which is d...
By Elise Haulund, Katherine Dillinger, Meg Tirrell, CNN (CNN) — The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults...
The agency had initially refused to even review the application but reversed course after a public outcry. The Food and Drug Administration on Wednesday approved the first mRNA flu...
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biot...
Experimental vaccines tailored to a tumor's mutations have cut recurrence risk in studies, but researchers caution that broad public use remains years away.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.